Here are 3 ASX 200 blue chip shares that analysts love

There's a lot to love about these high quality ASX 200 blue chips.

| More on:
Young woman using computer laptop smiling in love showing heart symbol and shape with hands. as she switches from a big telco to Aussie Broadband which is capturing more market share

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're interested in adding some ASX 200 blue chip shares to your portfolio this month, then the three listed below could be worth considering.

These ASX 200 shares have all been named as buys recently. Here's what you need to know about them:

Cochlear Limited (ASX: COH)

The first ASX 200 blue chip share to look at is Cochlear. It is one of the world's leading hearing solutions companies with a portfolio of industry-leading cochlear implant devices.

But management is never one to rest on its laurels. Each year, the company spends heavily on its research and development activities in order to stay ahead of the pack.

Goldman Sachs is a fan of Cochlear. It believes it is well-placed to outperform expectations in FY 2023. As a result, the broker has put a buy rating and $265.00 price target on its shares.

Goodman Group (ASX: GMG)

Another ASX 200 blue chip share that has been named as a buy is Goodman Group. It is one of the world's leading integrated commercial and industrial property companies.

Goodman has been growing at a consistently strong rate for years thanks to its expertly constructed portfolio that gives it exposure to key growth markets such as ecommerce and logistics.

The good news is that the team at Citi appears to believe this run can continue. Its analysts are forecasting double-digit earnings per share growth out until at least FY 2025.

It's no surprise then to learn that Citi has a buy rating on its shares with a $24.00 price target.

ResMed Inc. (ASX: RMD)

A final ASX 200 blue chip share to consider buying is ResMed. Like the others, it is an industry leader, this time in the sleep treatment market.

Also like the others, ResMed has been growing at a solid rate for years and has been tipped to continue doing so for the foreseeable future.

Morgans is among the brokers expecting big things from the company in the coming years. As a result, it has ResMed on its best ideas list with an add rating and $37.80 price target.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Cochlear and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A group of young people lined up on a wall are happy looking at their laptops and devices as they invest in the latest trendy stock.
Blue Chip Shares

Why these ASX 200 blue chip shares could generate big returns

Brokers think these shares are could be dirt cheap at current levels.

Read more »

Man sits smiling at a computer showing graphs
Blue Chip Shares

3 ASX shares Australians can buy and hold for the next decade

Analysts think these high quality stocks could be in the buy zone right now.

Read more »

2 women looking at phone
Blue Chip Shares

3 high quality blue chip ASX 200 shares to buy in November

Here are a few blue chip shares that have been rated as buys this month by analysts.

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Blue Chip Shares

2 of the highest-quality blue chip ASX 200 stocks money can buy

Analysts think these blue chips are top buys for investors right now. But why?

Read more »

Three smiling corporate people examine a model of a new building complex.
Blue Chip Shares

This blue chip ASX 200 stock is 'among the highest-quality names' under coverage

Goldman Sachs thinks this blue chip is a top buy.

Read more »

A business woman flexes her muscles overlooking a city scape below.
Blue Chip Shares

Brokers name 2 strong ASX 200 shares to buy now

These shares are among the top picks on the benchmark ASX 200 index according to analysts.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Blue Chip Shares

Up 47% in a year: This blue chip ASX 200 stock can keep rising

Bell Potter is feeling bullish about this stock. But why?

Read more »

A man looking at his laptop and thinking.
Blue Chip Shares

Should you buy Coles and Mineral Resources shares this month?

Are these blue chips buys? Let's see what Bell Potter is saying about them.

Read more »